FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2106948611> ?p ?o ?g. }

• W2106948611 endingPage "35" @default.
• W2106948611 startingPage "429" @default.
• W2106948611 abstract "Antiplatelet agents are often included in plasma exchange-based regimens for thrombotic thrombocytopenic purpura (TTP) patients; however, the opportuneness of their use in TTP is still controversial. The italian Cooperative Group for TTP carried out a randomized trial to investigate their actual effectiveness, both in acute TTP and as maintenance treatment.Seventy-two TTP patients were randomized to receive plasma exchange and steroids with (group B) or without (group A) aspirin and dipyridamole. Treatment efficacy was evaluated after 15 days and salvage treatments were also considered for non-responders. Upon disease remission, the patients already treated with antiplatelet agents received ticlopidine for one year.Regarding the treatment of acute phase TTP, similar overall response rates were observed in the two groups (91.4% in group B vs. 75.6% in group A), but lower mortality rates were observed at 15 days in the patients treated with antiplatelet agents; as a matter of fact, 5 patients from arm A died in the first 15 days (13.5%) versus only one in arm B (2.8%). These figures, while not statistically significant, seem to suggest that antiplatelet agents might be useful in preventing deaths in acute TTP; moreover, bleeding did not worsen in antiplatelet agent-treated patients. As for the role of maintenance treatment, our results support the efficacy and safety of one-year ticlopidine therapy since the current relapse rate is significantly higher in non-treated patients; as a matter of fact, 6 patients (21.4%) in the non-ticlopidine group and only 2 (6.25%) in the ticlopidine group relapsed (P = .0182 in favor of maintenance treatment).Our results suggest the usefulness of antiplatelet agents in the treatment of acute phase TTP patients. Moreover, one-year ticlopidine maintenance therapy appears to be beneficial in preventing TTP relapses; however, only the completion of an adequate follow-up for all patients will definitively confirm this observation." @default.
• W2106948611 created "2016-06-24" @default.
• W2106948611 creator A5016561659 @default.
• W2106948611 creator A5018910230 @default.
• W2106948611 creator A5019087367 @default.
• W2106948611 creator A5029722841 @default.
• W2106948611 creator A5037929932 @default.
• W2106948611 creator A5045651843 @default.
• W2106948611 creator A5080142310 @default.
• W2106948611 creator A5091887568 @default.
• W2106948611 date "1997-07-01" @default.
• W2106948611 modified "2023-09-30" @default.
• W2106948611 title "Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP." @default.
• W2106948611 cites W145789347 @default.
• W2106948611 cites W1586475557 @default.
• W2106948611 cites W1964100346 @default.
• W2106948611 cites W1977427621 @default.
• W2106948611 cites W1983759759 @default.
• W2106948611 cites W1984087280 @default.
• W2106948611 cites W1984838521 @default.
• W2106948611 cites W1998741071 @default.
• W2106948611 cites W2016861625 @default.
• W2106948611 cites W2036029513 @default.
• W2106948611 cites W2043201538 @default.
• W2106948611 cites W2047509396 @default.
• W2106948611 cites W2054759473 @default.
• W2106948611 cites W2063707971 @default.
• W2106948611 cites W2064757309 @default.
• W2106948611 cites W2064931105 @default.
• W2106948611 cites W2065316055 @default.
• W2106948611 cites W2071766779 @default.
• W2106948611 cites W2075324596 @default.
• W2106948611 cites W2080180049 @default.
• W2106948611 cites W2102867293 @default.
• W2106948611 cites W2120944287 @default.
• W2106948611 cites W2150290224 @default.
• W2106948611 cites W2155744453 @default.
• W2106948611 cites W2241081322 @default.
• W2106948611 cites W2241823290 @default.
• W2106948611 cites W2242448568 @default.
• W2106948611 cites W2245668983 @default.
• W2106948611 cites W2246293334 @default.
• W2106948611 cites W2287015884 @default.
• W2106948611 cites W2334213116 @default.
• W2106948611 cites W2340820189 @default.
• W2106948611 cites W2404209487 @default.
• W2106948611 cites W2414786362 @default.
• W2106948611 cites W2417388088 @default.
• W2106948611 cites W2418773538 @default.
• W2106948611 cites W2802798604 @default.
• W2106948611 cites W611274402 @default.
• W2106948611 cites W2186012206 @default.
• W2106948611 cites W2398730214 @default.
• W2106948611 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9299856" @default.
• W2106948611 hasPublicationYear "1997" @default.
• W2106948611 type Work @default.
• W2106948611 sameAs 2106948611 @default.
• W2106948611 citedByCount "43" @default.
• W2106948611 countsByYear W21069486112012 @default.
• W2106948611 countsByYear W21069486112014 @default.
• W2106948611 countsByYear W21069486112015 @default.
• W2106948611 countsByYear W21069486112016 @default.
• W2106948611 countsByYear W21069486112017 @default.
• W2106948611 countsByYear W21069486112018 @default.
• W2106948611 countsByYear W21069486112019 @default.
• W2106948611 countsByYear W21069486112020 @default.
• W2106948611 countsByYear W21069486112021 @default.
• W2106948611 countsByYear W21069486112022 @default.
• W2106948611 countsByYear W21069486112023 @default.
• W2106948611 crossrefType "journal-article" @default.
• W2106948611 hasAuthorship W2106948611A5016561659 @default.
• W2106948611 hasAuthorship W2106948611A5018910230 @default.
• W2106948611 hasAuthorship W2106948611A5019087367 @default.
• W2106948611 hasAuthorship W2106948611A5029722841 @default.
• W2106948611 hasAuthorship W2106948611A5037929932 @default.
• W2106948611 hasAuthorship W2106948611A5045651843 @default.
• W2106948611 hasAuthorship W2106948611A5080142310 @default.
• W2106948611 hasAuthorship W2106948611A5091887568 @default.
• W2106948611 hasConcept C126322002 @default.
• W2106948611 hasConcept C141071460 @default.
• W2106948611 hasConcept C168563851 @default.
• W2106948611 hasConcept C2776890861 @default.
• W2106948611 hasConcept C2777628954 @default.
• W2106948611 hasConcept C2777849778 @default.
• W2106948611 hasConcept C2778585876 @default.
• W2106948611 hasConcept C2778905298 @default.
• W2106948611 hasConcept C71924100 @default.
• W2106948611 hasConcept C89560881 @default.
• W2106948611 hasConceptScore W2106948611C126322002 @default.
• W2106948611 hasConceptScore W2106948611C141071460 @default.
• W2106948611 hasConceptScore W2106948611C168563851 @default.
• W2106948611 hasConceptScore W2106948611C2776890861 @default.
• W2106948611 hasConceptScore W2106948611C2777628954 @default.
• W2106948611 hasConceptScore W2106948611C2777849778 @default.
• W2106948611 hasConceptScore W2106948611C2778585876 @default.
• W2106948611 hasConceptScore W2106948611C2778905298 @default.
• W2106948611 hasConceptScore W2106948611C71924100 @default.
• W2106948611 hasConceptScore W2106948611C89560881 @default.

• next